Contents
Current Pharmaceutical Design, Volume 9 - Number 19
Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
, 9(19): 1483 - 1498Todd W. Rockway and Vincent L. Giranda
DOI: 10.2174/1381612033454649
Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
, 9(19): 1529 - 1543Ute Reuning, Stefan Sperl, Charlotte Kopitz, Horst Kessler, Achim Kruger, Manfred Schmitt and Viktor Magdolen
DOI: 10.2174/1381612033454612
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
, 9(19): 1545 - 1564Steingrimur Stefansson, Grainne A. McMahon, Eric Petitclerc and Daniel A. Lawrence
DOI: 10.2174/1381612033454621
Urokinase Receptor and Integrin Interactions
, 9(19): 1565 - 1574Matthias C. Kugler, Ying Wei and Harold A. Chapman
DOI: 10.2174/1381612033454658
Webmaster Contact: info@benthamscience.org